HC Wainwright Cuts ALX Oncology (NASDAQ:ALXO) Price Target to $2.00
ALX Oncology (NASDAQ:ALXO – Free Report) had its target price reduced by HC Wainwright from $5.00 to $2.00 in a research note published on Friday morning,Benzinga reports. They currently have a buy rating on the stock. A number of other analysts have also issued reports on the stock. UBS Group reduced their price target on […]
ALX Oncology (NASDAQ:ALXO – Free Report) had its target price reduced by HC Wainwright from $5.00 to $2.00 in a research note published on Friday morning,Benzinga reports. They currently have a buy rating on the stock. A number of other analysts have also issued reports on the stock. UBS Group reduced their price target on […]
